Neuland Laboratories

12,000.00
-120.00
(-0.99%)
Market Cap
15,395.87 Cr
EPS
233.89
PE Ratio
76.70
Dividend Yield
0.10 %
Industry
Healthcare
52 Week High
18,100.00
52 Week Low
7,496.05
PB Ratio
10.20
Debt to Equity
0.10
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,675.70
#1 4,02,056.56
35.31
#1 49,887.20
12.06
#1 9,648
-18.99
47.69
6,809.50
1,80,770.83
80.67
8,184.00
0.89
1,600
23.05
64.57
1,505.90
1,21,632.72
23.59
28,409.50
7.12
5,291
30.28
52.42
3,408.20
1,15,348.97
58.70
10,785.70
11.59
1,656
10.91
70.47
1,283.30
1,07,100.51
19.20
28,905.40
12.36
5,578
21.14
46.09
989.95
99,612.13
21.15
19,831.50
13.82
3,831
-0.19
69.55
2,319.80
95,744.81
48.50
10,615.60
19.57
1,942
-10.91
40.44
1,938.00
88,507.58
26.95
20,141.50
#1 19.94
1,936
#1 112.49
43.14
35,670.00
75,796.26
52.60
6,097.20
10.80
1,201
27.83
79.74
1,134.80
65,909.37
#1 18.88
29,559.20
17.55
3,169
-0.50
48.78

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
30.83 %
Net Income Growth
83.55 %
Cash Flow Change
10.10 %
ROE
42.19 %
ROCE
47.41 %
EBITDA Margin (Avg.)
28.96 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
155
169
172
174
182
187
205
193
206
242
246
259
203
258
238
257
222
294
270
415
365
421
395
390
465
315
458
336
Expenses
145
154
156
154
162
161
176
162
172
201
199
219
175
215
204
217
193
224
215
287
266
280
272
278
316
249
311
277
EBITDA
10
15
16
20
19
26
29
32
35
42
47
40
28
43
34
40
29
70
55
128
99
141
123
112
149
67
146
59
Operating Profit %
6 %
9 %
9 %
11 %
10 %
13 %
14 %
16 %
16 %
17 %
19 %
10 %
13 %
17 %
14 %
15 %
13 %
24 %
20 %
29 %
27 %
33 %
31 %
28 %
28 %
20 %
22 %
16 %
Depreciation
6
6
7
7
8
8
8
8
9
9
10
11
12
12
13
12
13
13
13
14
14
15
15
17
16
16
16
17
Interest
4
4
3
5
4
5
6
7
5
4
4
5
4
4
3
3
3
3
3
4
2
4
4
4
3
1
2
2
Profit Before Tax
1
5
6
8
8
12
16
17
20
29
32
24
12
28
18
24
14
53
39
110
83
122
105
92
130
49
128
39
Tax
0
1
1
2
2
4
5
27
5
7
5
7
3
7
5
3
4
15
8
26
21
32
23
25
32
17
26
12
Net Profit
1
5
5
7
6
9
11
-9
15
21
27
17
9
20
13
22
10
39
31
85
62
89
81
68
98
33
102
28
EPS in ₹
0.44
3.55
3.66
5.17
4.45
6.77
8.66
-7.25
11.82
16.71
20.84
13.48
6.81
15.88
10.08
16.97
7.77
29.97
23.81
65.90
48.23
69.56
63.44
52.66
76.28
25.60
79.18
21.67

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
512
524
886
1,071
1,130
1,231
1,325
1,384
1,580
1,833
Fixed Assets
123
139
466
475
542
653
716
767
758
824
Current Assets
316
314
375
447
454
515
550
581
761
921
Capital Work in Progress
42
41
20
126
105
24
17
21
41
46
Investments
0
0
8
8
8
8
7
4
1
1
Other Assets
347
345
393
463
477
547
585
592
781
962
Total Liabilities
512
524
886
1,071
1,130
1,231
1,325
1,384
1,580
1,833
Current Liabilities
295
268
286
367
327
358
369
363
439
428
Non Current Liabilities
55
69
54
146
104
163
170
180
147
122
Total Equity
162
187
546
558
699
710
787
841
994
1,283
Reserve & Surplus
152
178
537
549
686
697
774
828
981
1,270
Share Capital
9
9
9
9
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
1
-4
-0
5
3
-9
3
40
42
Investing Activities
-14
-20
-42
-116
-77
-49
-85
-95
-61
-150
Operating Activities
13
45
39
11
70
57
189
60
237
261
Financing Activities
1
-24
-0
105
12
-6
-114
38
-136
-69

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.14 %
36.14 %
36.03 %
35.97 %
32.80 %
32.74 %
32.72 %
32.64 %
32.68 %
32.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
21.57 %
22.69 %
24.44 %
25.72 %
26.46 %
23.86 %
22.11 %
DIIs
0.87 %
0.04 %
0.80 %
0.80 %
0.80 %
0.80 %
6.58 %
6.55 %
7.10 %
6.76 %
6.99 %
6.03 %
6.54 %
6.39 %
6.38 %
9.08 %
10.97 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.44 %
0.46 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
Public / Retail
34.06 %
36.62 %
33.19 %
32.84 %
32.43 %
33.25 %
31.03 %
30.09 %
29.86 %
29.01 %
27.86 %
29.51 %
27.97 %
27.05 %
26.50 %
26.05 %
25.86 %
Others
28.85 %
27.12 %
29.80 %
30.15 %
30.56 %
29.74 %
25.73 %
26.76 %
26.51 %
27.80 %
7.21 %
8.57 %
7.91 %
7.71 %
7.61 %
7.93 %
7.99 %
No of Share Holders
0
22,412
34,978
34,332
32,426
32,257
31,976
30,600
26,948
25,223
26,824
27,723
28,616
29,077
34,567
39,315
39,333

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 2 5 5 10 14 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.1 0.49 0.28 0.16 0.12 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2025 12,472.30 12,118.80
18 Jul 2025 DIVIDEND Dividend
₹ 12.00 /share
18 Jul 2025 12,472.30 12,118.80
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 12,820.80 12,472.30
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 13,869.35 14,247.35
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 16,250.70 15,858.20
31 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2024 7,146.85 9,051.20
13 Jul 2024 DIVIDEND Dividend
₹ 14.00 /share
12 Jul 2024 7,146.85 8,094.80
12 Jul 2023 DIVIDEND Dividend
₹ 10.00 /share
11 Jul 2023 2,115.25 2,998.80
15 Jul 2022 DIVIDEND Dividend
₹ 5.00 /share
14 Jul 2022 1,334.25 1,298.00
01 Jul 2021 DIVIDEND Dividend
₹ 3.00 /share
29 Jun 2021 2,692.70 2,142.20

Announcements

Disclosure Under Regulation 30 Of SEBI Listing Regulations2 days ago
Closure of Trading Window4 days ago
Announcement under Regulation 30 (LODR)-Credit Rating9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Disclosure Under Regulation 30 Of SEBI Listing RegulationsJun 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 17, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 11, 2025
Compliance Certificate Pursuant To SEBI Exemption Order Dated January 3 2025 For The Financial Year Ended March 31 2025Jun 10, 2025
Clarification sought from Neuland Laboratories LtdJun 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 19, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateMay 19, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 15, 2025
41St Annual General Meeting Of The Shareholders Of The Company Is Scheduled To Be Held On Wednesday July 30 2025May 15, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 15, 2025
The Record Date For The Purpose Of Determining The Shareholder Eligible To Receive The Final Dividend For The Financial Year Ended March 31 2025 Has Been Fixed As July 18 2025May 15, 2025
Appointment Of Secretarial Auditors Of The CompanyMay 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 15, 2025
Corporate Action-Board approves DividendMay 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2025
Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2024-25May 15, 2025
Board Meeting Outcome for Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2024-25May 15, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 05, 2025
Intimation Regarding Completion Of US FDA InspectionMay 02, 2025
Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025 And; To Recommend Final Dividend If Any For The Financial Year Ended MaApr 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2025
Closure of Trading WindowMar 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 19, 2025
Announcement under Regulation 30 (LODR)-Credit RatingMar 10, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 10, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 03, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 25, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Integrated Filing (Financial)Feb 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2025
Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024Feb 10, 2025
Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024Feb 10, 2025

Technical Indicators

RSI(14)
Neutral
48.21
ATR(14)
Less Volatile
472.92
STOCH(9,6)
Oversold
18.06
STOCH RSI(14)
Oversold
7.65
MACD(12,26)
Bearish
-80.94
ADX(14)
Weak Trend
16.85
UO(9)
Bearish
37.77
ROC(12)
Downtrend But Slowing Down
-9.30
WillR(14)
Oversold
-85.75

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HSBC Small Cap Fund Direct-Growth
1.66%
-30267
-0.47%
-0.68%
ICICI Prudential Flexicap Fund Direct - Growth
1.30%
10423
-0.05%
0.02%
JM Aggressive Hybrid Fund Direct-Growth
0.00%
-9500
-1.42%
-1.49%
HSBC Multi Cap Fund Direct - Growth
1.14%
-9417
-0.37%
-0.45%
LIC MF ELSS Tax Saver Direct - Growth
0.52%
5056
0.52%
0.52%
Sundaram Small Cap Fund Direct-Growth
1.56%
4444
-0.03%
-0.09%
JM Small Cap Fund Direct - Growth
1.54%
-4000
-1.05%
-1.23%
Bajaj Finserv Flexi Cap Fund Direct-Growth
0.79%
3829
0.01%
-0.06%
WhiteOak Capital Special Opportunities Fund Direct - Growth
0.94%
2467
0.20%
0.13%
Axis Equity Savings Fund Direct-Growth
0.07%
-1919
-0.25%
-0.25%
Bandhan Small Cap Fund Direct-Growth
0.52%
1600
-0.09%
-0.13%
WhiteOak Capital Flexi Cap Fund Direct - Growth
0.36%
1356
-0.01%
-0.04%
LIC MF Small Cap Fund Direct - Growth
1.33%
907
0.00%
1.33%
WhiteOak Capital Multi Cap Fund Direct - Growth
0.36%
845
0.01%
-0.03%
LIC MF Healthcare Fund Direct - Growth
4.11%
827
1.00%
0.82%
ITI Small Cap Fund Direct-Growth
1.03%
611
-0.11%
-0.16%
LIC MF Dividend Yield Fund Direct - Growth
1.49%
485
-0.10%
0.08%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
1.57%
444
0.04%
0.10%
Bandhan Innovation Fund Direct-Growth
0.89%
-210
-0.11%
-0.15%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.52%
204
-0.07%
-0.06%
ITI Pharma and Healthcare Fund Direct - Growth
1.98%
200
0.01%
-0.30%
WhiteOak Capital ELSS Tax Saver Fund Direct - Growth
0.44%
172
0.01%
-0.01%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.52%
127
-0.07%
-0.09%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.52%
85
-0.07%
-0.09%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.52%
55
-0.07%
-0.09%